Analyst Ratings for Bristol-Myers Squibb Co. (BMY)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/28/2011 | CLSA | N/A | Downgrade | Underperform (N/A) |
35.00 (N/A) |
32.62 (35.29) |
8.19% | Details |
| 10/19/2011 | MKM Partners | N/A | New Coverage | Sell (N/A) |
26.00 (N/A) |
32.56 (35.29) |
8.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
